COLTENE Holding AG · SIX:CLTN
COLTENE — Investora 2020
23 slides from COLTENE's conference presentation, Sep 23, 2020

Slide 1: Investora 2020
Investora 2020 Gerhard Mahrle, CFO Zürich - September 23, 2020

Slide 2: Safe Harbor Statement
Safe Harbor Statement This written statement and oral statements or other statements made, or to be made, by us contain forward-looking statements that do not relate solely to historical or current facts. These forward-looking statements are based on the current plans and expectations of our managem

Slide 3: Agenda
Agenda COLTENE – Presentation at Investora 2020 Company Portrait COVID-19 Impact Response to COVID-19 pandemic Strategy and Outlook Q&A 3

Slide 4: Company Portrait
Company Portrait ” COLTENE

Slide 5: COLTENE at a glance
COLTENE at a glance Dental supplier in niche markets • COLTENE develops, manufactures and markets premium dental materials and small equipment for dental practices. • 6 legal manufacturing sites • MedTech products of class 1, 2a, 2b, 3 • 14 sales entities supported by over 300 sales reps • 3 product

Slide 6: Comprehensive product portfolio for dental treatments
Comprehensive product portfolio for dental treatments Dentists around the world rely on COLTENE products Infection Control Dental Preservation Efficient Treatment „The infection „Sustainable preservation „Smart & efficient control specialist“ from root to crown“ utilities dentists rely on“ Instrumen

Slide 7: COLTENE has a true global setup
COLTENE has a true global setup Own sales force all around the world North America Group companies 4 Production sites 2 Workforce (FTE) 620 36% Latin America CHF 98 m 45% Group companies 1 CHF 125 m Production sites 1 Workforce (FTE) 120 Europe EMEA 12% Group companies 20 7% CHF 33 m Production site

Slide 8: COLTENE products are available around the world
COLTENE products are available around the world Business model Operation Germany Textile/Paper/Hygiene Sales Distributors Servicing dentists Warehouse EMEA Europe Operation Switzerland Chemical Products Sales Distributors Asia, ROW Warehouse USA Operations NAM Sales Latin America Distributors Electr

Slide 9: COLTENE production and R&D locations
COLTENE production and R&D locations Specialized state-of-the-art production facilities Altstätten Dental Preservation Dental Preservation Toronto Canada Infection Control Langenau Germany Switzerland Efficient Treatment Efficient Treatment Cuyahoga Falls/OH Infection Control Dental Preservation Rio

Slide 10: Adressable market
Adressable market Dental consumables and small equipment Relevant market size in 2020: ~ CHF 5.8 billion Relevant market size by segment in % 22% Infection Control (39%) 42% Dental Preservation (26%) 36% Efficient Treatment (35%) (percentage of net sales of COLTENE) COLTENE is an important player in

Slide 11: COVID-19 Impact
COVID-19 Impact Photo: Dr. Benjamin Ezeh - Manager R&D Endodontics Coltène/Whaledent AG, Altstätten, Switzerland

Slide 12: Net sales by product groups
Net sales by product groups Products in the area Infection Control are in great demand Net sales H1 2020 by product groups Net sales H1 2020 by product groups (in CHF 1’000) (shares) H1 2019 H1 2020 60'000 55'900 50'000 43'091 35% 40'890 39% 40'000 36'400 36'283 30'000 26'715 20'000 26% 10'000 0 Inf

Slide 13: Net sales by product groups
Net sales by product groups Outstanding development in Q1 was heavily impacted by the COVID-19 pandemic Sales development H1/2020 in TCHF 12'000 140'000 10'000 120'000 8'000 100'000 80'000 COVID-19 and a very 6'000 strong CHF are heavily 60'000 impacting COLTENE’s 4'000 40'000 turnover in H1/2020! 2

Slide 14: EBIT development
EBIT development In CHF million EBIT Bridge YTD PY to ACT - in CHF mn 15.0 10.0 5.0 12.8 [WERT].1 [WERT].3 2.6 0.0 +5.9 Net Sales 3rd decline mainly -5.0 -31.5 Favorable development of OPEX [WERT].0 driven by Covid-19 impact and -10.0 of 5.9 mn driven by reduction of negative currency impacts costs

Slide 15: Response to COVID-19 pandemic
Response to COVID-19 pandemic Photo: med. dent. Zita Baumeler Savary – Dentist Altstätten, Switzerland

Slide 16: Response to COVID-19 pandemic
Response to COVID-19 pandemic A comprehensive set of measures Financials Net sales CHF 103.9 mn; -19.2% in local currencies compared to H1 2019, -23.3% in reporting currency Swiss francs EBIT margin stood at 2.5% (H1 2019: 9.4%), EBIT remained positive despite sharp fall due to COVID-19 pandemic N

Slide 17: Infection Control: the measures in detail
Infection Control The measures in detail Employees Cost Reductions Product Portfolio Marketing & Sales Integration • Temporary positions • Personnel expenses were • Biosonic Wipes integrated • Marketing expenses were • Manufacturing of Kenda eliminated, but all regular 14% lower in H1, year-on- into

Slide 18: Strategy and Outlook
Strategy and Outlook Gerhard Mahrle, CFO

Slide 19: Dental industry
Dental industry Mega trends Globalization and e-commerce Increasing requirements in distribution regarding quality management and regulatory affairs (MDR) Negative trend in volume due to Digitalization in better oral health in Consolidation • the dental processes developed countries in manufacturing

Slide 20: What can we expect in 2020?
What can we expect in 2020? Impact by and recovery from COVID-19 Impact Q1 strong and positive start into the current year Q2 high impact from government’s closing of dental practices in many key countries; upside from Infection Control Q3 hope to return gradually to normality Q4 new normal is exp

Slide 21: Milestones 2020 and summary
Milestones 2020 and summary COVID-19 impact mitigated Immediate reactions in Strategic focus on Infection Adjust business to new normal with protecting employees and Control and the acquisitions investments in customer relations, business as well as cost of SciCan and Micro-Mega product innovation,

Slide 22: Q&A
Infection Control A Q&A ” COLTENE

Slide 23: Thank you!
Thank you! COLTENE Holding AG Gerhard Mahrle, CFO Feldwiesenstrasse 20 9450 Altstätten Switzerland +41 71 757 53 80 investor@coltene.com
Source: Internet Archive copy of ap.coltene.com
More decks from COLTENE Holding AG
FY2025 Earnings Presentation27 slides · Mar 6, 2026
H1 2023 Earnings Presentation20 slides · Aug 4, 2023
Investor Presentation (July 2023)20 slides · July 2023
FY2021 Earnings Presentation32 slides · Mar 4, 2022
H1 2021 Earnings Presentation28 slides · Aug 6, 2021
FY2020 Earnings Presentation36 slides · Mar 5, 2021